{"product_id":"ada-86th-scientific-sessions-2026-complete-bundle","title":"ADA 86th Scientific Sessions 2026 – Complete Bundle","description":"\u003cdiv class=\"form-group\"\u003e\r\n\u003cdiv class=\"form-control-plaintext\"\u003e\r\n\u003cdiv class=\"form-group\"\u003e\r\n\u003ch1\u003eAmerican Diabetes Association (ADA) 86th Scientific Sessions 2026 – Complete Bundle (Videos + ePosters)\u003c\/h1\u003e\r\n\u003ch2\u003eComprehensive Updates in Diabetes, Obesity, Endocrinology, GLP-1 Therapies, Artificial Intelligence, Cardiometabolic Medicine, and Precision Diabetes Care\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eStay at the forefront of diabetes research and clinical practice with the \u003cstrong\u003eAmerican Diabetes Association (ADA) 86th Scientific Sessions 2026 – Complete Bundle\u003c\/strong\u003e, the most comprehensive educational collection from the world's largest diabetes conference. Featuring \u003cstrong\u003emore than 200 expert-led educational sessions and over 100 scientific ePosters\u003c\/strong\u003e, this extensive program delivers the latest breakthroughs in diabetes, obesity, endocrinology, metabolism, cardiovascular disease, kidney disease, diabetes technology, and precision medicine.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe \u003cstrong\u003eADA 86th Scientific Sessions 2026\u003c\/strong\u003e brings together internationally recognized clinicians, researchers, endocrinologists, diabetes specialists, scientists, and healthcare professionals to present cutting-edge clinical research, landmark clinical trials, emerging therapies, and evidence-based guidelines that are transforming diabetes prevention and treatment worldwide.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThrough symposia, expert panel discussions, late-breaking clinical trials, scientific presentations, and research posters, participants gain practical insights into the newest pharmacologic therapies, artificial intelligence, continuous glucose monitoring, insulin innovations, obesity medicine, cardiovascular risk reduction, chronic kidney disease, metabolic health, and future directions in diabetes care.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eWhether you manage patients with \u003cstrong\u003eType 1 Diabetes, Type 2 Diabetes, obesity, metabolic syndrome, cardiovascular disease, or endocrine disorders\u003c\/strong\u003e, this comprehensive bundle provides one of the most complete educational resources available in modern diabetes medicine.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eProduct Details\u003c\/h1\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse:\u003c\/strong\u003e ADA 86th Scientific Sessions 2026 – Complete Bundle\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eProvider:\u003c\/strong\u003e American Diabetes Association (ADA)\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eConference:\u003c\/strong\u003e ADA 86th Scientific Sessions 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e Videos + ePosters (PDF)\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eContent Included:\u003c\/strong\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\u003cstrong\u003e200+ Expert-Led Videos\u003c\/strong\u003e\u003c\/li\u003e\r\n \t\u003cli\u003e\u003cstrong\u003e100+ Scientific ePosters (PDF)\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eEducational Level:\u003c\/strong\u003e Intermediate to Advanced\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eCourse Overview\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe \u003cstrong\u003eAmerican Diabetes Association Scientific Sessions\u003c\/strong\u003e represents the premier global scientific meeting dedicated to diabetes, endocrinology, obesity, and metabolic medicine. Each year, leading investigators present the newest discoveries that influence clinical guidelines and shape the future of diabetes care.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe \u003cstrong\u003eADA 86th Scientific Sessions 2026 Complete Bundle\u003c\/strong\u003e offers comprehensive access to groundbreaking educational content covering every aspect of diabetes management—from prevention and early diagnosis to advanced therapeutics, technology, precision medicine, and long-term complication management.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eParticipants explore landmark clinical trials, innovative pharmacologic therapies, next-generation incretin medications, artificial intelligence applications, cardiometabolic disease management, obesity treatment, diabetes technologies, and translational research that can be immediately integrated into clinical practice.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhat You'll Learn\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eAfter completing this course, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eApply the latest ADA evidence-based recommendations for diabetes management.\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrate new GLP-1 receptor agonists and emerging incretin therapies into patient care.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate landmark clinical trial results for Type 1 and Type 2 diabetes.\u003c\/li\u003e\r\n \t\u003cli\u003eOptimize cardiovascular, renal, and metabolic outcomes using modern treatment strategies.\u003c\/li\u003e\r\n \t\u003cli\u003eIncorporate artificial intelligence and digital technologies into diabetes care.\u003c\/li\u003e\r\n \t\u003cli\u003eImprove obesity management through pharmacologic and lifestyle interventions.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize continuous glucose monitoring and diabetes technologies effectively.\u003c\/li\u003e\r\n \t\u003cli\u003eTranslate cutting-edge scientific research into daily clinical practice.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eComprehensive Topics Covered\u003c\/h1\u003e\r\n\u003ch2\u003eType 1 Diabetes\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview the latest advances in the diagnosis, treatment, and long-term management of Type 1 Diabetes.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAdjunctive therapies\u003c\/li\u003e\r\n \t\u003cli\u003eGLP-1\/GIP dual agonists\u003c\/li\u003e\r\n \t\u003cli\u003eCT-868 clinical trials\u003c\/li\u003e\r\n \t\u003cli\u003eInsulin optimization\u003c\/li\u003e\r\n \t\u003cli\u003eContinuous glucose monitoring\u003c\/li\u003e\r\n \t\u003cli\u003ePrecision medicine\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eType 2 Diabetes\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eExplore evidence-based approaches for improving glycemic control and reducing long-term complications.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eIndividualized treatment strategies\u003c\/li\u003e\r\n \t\u003cli\u003eEarly intervention\u003c\/li\u003e\r\n \t\u003cli\u003eCombination therapies\u003c\/li\u003e\r\n \t\u003cli\u003ePharmacologic advances\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle management\u003c\/li\u003e\r\n \t\u003cli\u003eLong-term outcomes\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eGLP-1 Receptor Agonists\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview the newest developments in incretin-based therapies that are reshaping diabetes and obesity treatment.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eGLP-1 receptor agonists\u003c\/li\u003e\r\n \t\u003cli\u003eEmerging therapeutic agents\u003c\/li\u003e\r\n \t\u003cli\u003eClinical efficacy\u003c\/li\u003e\r\n \t\u003cli\u003eCardiovascular protection\u003c\/li\u003e\r\n \t\u003cli\u003eWeight reduction\u003c\/li\u003e\r\n \t\u003cli\u003eFuture treatment strategies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eFaculty review the latest scientific evidence supporting GLP-1 therapy in modern diabetes care.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eCagriSema \u0026amp; REIMAGINE Clinical Trials\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eGain insight into one of the most anticipated diabetes clinical trial programs.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eREIMAGINE 1\u003c\/li\u003e\r\n \t\u003cli\u003eREIMAGINE 2\u003c\/li\u003e\r\n \t\u003cli\u003eREIMAGINE 3\u003c\/li\u003e\r\n \t\u003cli\u003eCagriSema\u003c\/li\u003e\r\n \t\u003cli\u003eAmylin analogs\u003c\/li\u003e\r\n \t\u003cli\u003eCombination incretin therapy\u003c\/li\u003e\r\n \t\u003cli\u003eType 2 Diabetes management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eOrforglipron (ACHIEVE Program)\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview the emerging era of oral incretin therapies.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eOrforglipron\u003c\/li\u003e\r\n \t\u003cli\u003eACHIEVE Clinical Trial Program\u003c\/li\u003e\r\n \t\u003cli\u003eOral GLP-1 therapy\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment innovation\u003c\/li\u003e\r\n \t\u003cli\u003ePatient adherence\u003c\/li\u003e\r\n \t\u003cli\u003eFuture therapeutic options\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eArtificial Intelligence in Diabetes\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eExplore how AI is transforming diabetes care and clinical decision-making.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eArtificial Intelligence\u003c\/li\u003e\r\n \t\u003cli\u003ePredictive analytics\u003c\/li\u003e\r\n \t\u003cli\u003eClinical decision support\u003c\/li\u003e\r\n \t\u003cli\u003eDigital health\u003c\/li\u003e\r\n \t\u003cli\u003ePersonalized medicine\u003c\/li\u003e\r\n \t\u003cli\u003eHealthcare innovation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eCardiometabolic Medicine\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eUnderstand the interconnected management of diabetes, cardiovascular disease, kidney disease, and obesity.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCardiovascular risk reduction\u003c\/li\u003e\r\n \t\u003cli\u003eChronic kidney disease\u003c\/li\u003e\r\n \t\u003cli\u003eHeart failure\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic syndrome\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrated patient care\u003c\/li\u003e\r\n \t\u003cli\u003eCardiorenal protection\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eHypoglycemia Prevention\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview innovative strategies for minimizing hypoglycemia while optimizing glycemic control.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHypoglycemia physiology\u003c\/li\u003e\r\n \t\u003cli\u003eRisk assessment\u003c\/li\u003e\r\n \t\u003cli\u003eNew therapeutic options\u003c\/li\u003e\r\n \t\u003cli\u003eTechnology-assisted prevention\u003c\/li\u003e\r\n \t\u003cli\u003eClinical management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eObesity Medicine\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eLearn the newest evidence supporting obesity management as an integral component of diabetes care.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eObesity pharmacotherapy\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle intervention\u003c\/li\u003e\r\n \t\u003cli\u003eWeight management\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic health\u003c\/li\u003e\r\n \t\u003cli\u003ePrecision obesity care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDiabetes Technology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview rapidly evolving technologies improving diabetes management.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eContinuous glucose monitoring (CGM)\u003c\/li\u003e\r\n \t\u003cli\u003eSmart insulin delivery\u003c\/li\u003e\r\n \t\u003cli\u003eDigital therapeutics\u003c\/li\u003e\r\n \t\u003cli\u003eConnected healthcare\u003c\/li\u003e\r\n \t\u003cli\u003eWearable technologies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eClinical Trials \u0026amp; Translational Research\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eStay current with the latest landmark studies presented at ADA Scientific Sessions.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eLate-breaking clinical trials\u003c\/li\u003e\r\n \t\u003cli\u003eTranslational medicine\u003c\/li\u003e\r\n \t\u003cli\u003ePrecision endocrinology\u003c\/li\u003e\r\n \t\u003cli\u003eEmerging therapies\u003c\/li\u003e\r\n \t\u003cli\u003eFuture research directions\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eLearning Objectives\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eUpon completion of this educational activity, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eApply current ADA evidence-based recommendations to diabetes management.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate new pharmacologic therapies including GLP-1 receptor agonists, oral incretins, and combination therapies.\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrate cardiovascular and renal protective strategies into diabetes treatment.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize diabetes technologies and artificial intelligence to improve patient outcomes.\u003c\/li\u003e\r\n \t\u003cli\u003eInterpret findings from landmark clinical trials and translational research.\u003c\/li\u003e\r\n \t\u003cli\u003eOptimize individualized care for patients with diabetes, obesity, and cardiometabolic disease.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eEducational Highlights\u003c\/h1\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eType 1 Diabetes\u003c\/li\u003e\r\n \t\u003cli\u003eType 2 Diabetes\u003c\/li\u003e\r\n \t\u003cli\u003eGLP-1 Receptor Agonists\u003c\/li\u003e\r\n \t\u003cli\u003eGIP Agonists\u003c\/li\u003e\r\n \t\u003cli\u003eAmylin Analogues\u003c\/li\u003e\r\n \t\u003cli\u003eCagriSema\u003c\/li\u003e\r\n \t\u003cli\u003eOrforglipron\u003c\/li\u003e\r\n \t\u003cli\u003eACHIEVE Clinical Trial Program\u003c\/li\u003e\r\n \t\u003cli\u003eArtificial Intelligence\u003c\/li\u003e\r\n \t\u003cli\u003eDiabetes Technology\u003c\/li\u003e\r\n \t\u003cli\u003eContinuous Glucose Monitoring (CGM)\u003c\/li\u003e\r\n \t\u003cli\u003eCardiometabolic Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eChronic Kidney Disease\u003c\/li\u003e\r\n \t\u003cli\u003eObesity Medicine\u003c\/li\u003e\r\n \t\u003cli\u003ePrecision Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eEndocrinology\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Trials\u003c\/li\u003e\r\n \t\u003cli\u003eScientific ePosters\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eContinuing Medical Education (CME)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhy This Course Stands Out\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe \u003cstrong\u003eADA 86th Scientific Sessions 2026 – Complete Bundle\u003c\/strong\u003e represents one of the world's most comprehensive educational resources in diabetes and endocrinology. Combining \u003cstrong\u003e200+ educational sessions\u003c\/strong\u003e with \u003cstrong\u003e100+ scientific ePosters\u003c\/strong\u003e, the program offers unparalleled access to the latest clinical evidence, landmark research, innovative therapeutics, and future treatment strategies. From next-generation incretin therapies and artificial intelligence to cardiometabolic medicine and obesity management, this bundle equips healthcare professionals with the knowledge needed to deliver state-of-the-art diabetes care.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eTarget Audience\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis educational activity is ideal for:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eEndocrinologists\u003c\/li\u003e\r\n \t\u003cli\u003eDiabetologists\u003c\/li\u003e\r\n \t\u003cli\u003eInternal Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eObesity Medicine Specialists\u003c\/li\u003e\r\n \t\u003cli\u003eCardiologists\u003c\/li\u003e\r\n \t\u003cli\u003eNephrologists\u003c\/li\u003e\r\n \t\u003cli\u003eHospitalists\u003c\/li\u003e\r\n \t\u003cli\u003eFamily Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eDiabetes Educators\u003c\/li\u003e\r\n \t\u003cli\u003eNurse Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003ePhysician Assistants\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Pharmacists\u003c\/li\u003e\r\n \t\u003cli\u003eEndocrinology Fellows\u003c\/li\u003e\r\n \t\u003cli\u003eInternal Medicine Residents\u003c\/li\u003e\r\n \t\u003cli\u003eResearchers involved in diabetes and metabolic disease\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhy Choose This Course?\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eWhether you specialize in endocrinology, internal medicine, primary care, cardiology, nephrology, or obesity medicine, the \u003cstrong\u003eAmerican Diabetes Association 86th Scientific Sessions 2026 – Complete Bundle\u003c\/strong\u003e provides an outstanding evidence-based review of modern diabetes care. Featuring world-renowned experts, groundbreaking clinical trials, innovative therapies, cutting-edge technology, and the latest ADA scientific updates, this program delivers the knowledge needed to improve outcomes for patients with diabetes and cardiometabolic disease.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003e\u003c\/h2\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43163709702242,"sku":"MED-AMB09642","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ADA-86th-Scientific-Sessions-2026-_E2_80_93-Complete-Bundle.jpg?v=1785419479","url":"https:\/\/meducourse.com\/products\/ada-86th-scientific-sessions-2026-complete-bundle","provider":"Meducourse","version":"1.0","type":"link"}